将抗菌药物耐药监测与医疗环境抗生素政策关联:COMBACTE-Magnet EPI-Net COACH项目
该系统综述旨在系统总结如何收集、分析和报告抗菌药物耐药(AMR)监测数据,以指导抗菌药物管理(AMS)团队提供经验性抗生素治疗建议。结论指出,综合的AMR监测报告流程对AMS干预至关重要,且应扩展至长期护理、门诊和兽医等非急性护理环境。
要点
- AMR监测数据应支持AMS团队优化经验性抗生素治疗。
- 监测报告流程需整合并扩展至长期护理、门诊和兽医环境。
- 缺乏适当AMR监测时,AMS政策可能无法有效对抗多重耐药病原体。
核心结论
- 本综述总结的证据为开发更综合的AMR监测数据报告流程以驱动AMS干预提供了有用基础。
- 这些流程应扩展至急性护理机构之外的环境,如长期护理、门诊和兽医环境。
- 没有适当的AMR监测,AMS政策的实施无法有效对抗多重耐药病原体,甚至可能加重不良事件负担。
研究设计与样本
- 研究组使用健康研究优先设置良好实践清单的9个要素和改良3D组合方法矩阵,确定了10个关于AMR监测与AMS关联的关键问题。
- 对已发表的关于AMR监测与AMS关联的原始研究和指南进行了系统综述。
主要发现
- 确定的关键问题聚焦于AMS团队组成、AMR监测最低基础设施要求、应报告的微生物/样本/药敏模式、数据分层策略、报告频率、驱动经验性治疗的耐药阈值、高风险医院单元/长期护理/门诊/兽医环境中的监测以及来自其他国家的监测数据。
临床怎么用
- 临床应建立整合的AMR监测数据报告流程,以支持AMS团队提供经验性抗生素治疗建议。
- 监测和报告流程应不仅限于急性护理机构,还应覆盖长期护理、门诊和兽医环境。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To systematically summarize the evidence on how to collect, analyse and report antimicrobial resistance (AMR) surveillance data to inform antimicrobial stewardship (AMS) teams providing guidance on empirical antibiotic treatment in healthcare settings. METHODS: The research group identified 10 key questions about the link between AMR surveillance and AMS using a checklist of 9 elements for good practice in health research priority settings and a modified 3D combined approach matrix, and conducted a systematic review of published original studies and guidelines on the link between AMR surveillance and AMS. RESULTS: The questions identified focused on AMS team composition; minimum infrastructure requirements for AMR surveillance; organisms, samples and susceptibility patterns to report; data stratification strategies; reporting frequency; resistance thresholds to drive empirical therapy; surveillance in high-risk hospital units, long-term care, outpatient and veterinary settings; and surveillance data from other countries. Twenty guidelines and seven original studies on the implementation of AMR surveillance as part of an AMS programme were included in the literature review. CONCLUSIONS: The evidence summarized in this review provides a useful basis for a more integrated process of developing procedures to report AMR surveillance data to drive AMS interventions. These procedures should be extended to settings outside the acute-care institutions, such as long-term care, outpatient and veterinary. Without proper AMR surveillance, implementation of AMS policies cannot contribute effectively to the fight against MDR pathogens and may even worsen the burden of adverse events from such interventions.
引用
- Pezzani MD, Mazzaferri F, Compri M, et al. Linking antimicrobial resistance surveillance to antibiotic policy in healthcare settings: the COMBACTE-Magnet EPI-Net COACH project. J Antimicrob Chemother. 2020. PMID: 33280049. doi:10.1093/jac/dkaa425
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。